A valid prescription requires a telehealth consultation with a licensed provider. No medication is dispensed without clinical evaluation.
NAD+ 100mg/mL
Investigational Mitochondrial Coenzyme
Compound Specifications
NAD+ 100mg/mL
Investigational Mitochondrial Coenzyme
NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme found in living cells that has been investigated in scientific research for its potential role in mitochondrial energy metabolism, sirtuin pathway signaling, and DNA repair processes. This is an investigational compound; these statements have not been evaluated by the FDA and it is not intended to diagnose, treat, cure, or prevent disease.
Investigated in laboratory research as a cofactor in mitochondrial electron transport and cellular ATP generation, and studied for its interactions with PARP DNA repair enzymes and sirtuin signaling pathways. Results may vary; individual outcomes depend on baseline health, adherence, and other factors.
Documented Therapeutic Benefits
Results may vary. Individual outcomes depend on adherence, baseline health, and other factors.
Subcutaneous or intramuscular injection 2-3 times weekly.
Frequently Asked Clinical Questions
Is injectable NAD+ better than oral supplements?
Research literature has explored injectable NAD+ for potential differences in bioavailability compared with oral forms, which may be subject to intestinal degradation. Individual responses vary and should be discussed with a qualified medical professional or your primary care physician.